Modelling interrupted time series to evaluate prevention and control of infection in healthcare

Epidemiology and Infection
Val GebskiDavid Kleinbaum

Abstract

The most common methods for evaluating interventions to reduce the rate of new Staphylococcus aureus (MRSA) infections in hospitals use segmented regression or interrupted time-series analysis. We describe approaches to evaluating interventions introduced in different healthcare units at different times. We compare fitting a segmented Poisson regression in each hospital unit with pooling the individual estimates by inverse variance. An extension of this approach to accommodate potential heterogeneity allows estimates to be calculated from a single statistical model: a 'stacked' model. It can be used to ascertain whether transmission rates before the intervention have the same slope in all units, whether the immediate impact of the intervention is the same in all units, and whether transmission rates have the same slope after the intervention. The methods are illustrated by analyses of data from a study at a Veterans Affairs hospital. Both approaches yielded consistent results. Where feasible, a model adjusting for the unit effect should be fitted, or if there is heterogeneity, an analysis incorporating a random effect for units may be appropriate.

Associated Clinical Trials

References

Aug 27, 1987·The New England Journal of Medicine·S B SoumeraiS Gortmaker
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
May 29, 1998·International Journal of Epidemiology·C Fernández-PérezM Carrasco
Jan 29, 2000·Statistics in Medicine·H J KimD N Midthune
Aug 18, 2001·Prevention Science : the Official Journal of the Society for Prevention Research·A BiglanA C Wagenaar
Aug 14, 2002·Journal of Clinical Pharmacy and Therapeutics·A K WagnerD Ross-Degnan
Dec 20, 2002·The New England Journal of Medicine·Jeanne M MaddenUNKNOWN Health maintenance organization
Jul 5, 2003·The Annals of Pharmacotherapy·Lloyd K MatoweJoan M Korth-Bradley
Dec 21, 2004·Biometrics·Hyune-Ju KimEric J Feuer
Feb 25, 2005·The Journal of Antimicrobial Chemotherapy·Peter G M MolFlora M Haaijer-Ruskamp
Sep 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susan S HuangRichard Platt
Nov 10, 2006·BMC Medical Research Methodology·Celia A Brown, Richard J Lilford
Sep 7, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michelle ShardellEli N Perencevich
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Dec 8, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Pei-Jean I FengJohn A Jernigan
Dec 8, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Katherine EllingsonJohn Jernigan
Sep 15, 2011·Biostatistics·Ian C Marschner, Alexandra C Gillett

❮ Previous
Next ❯

Citations

May 17, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Priti R PatelAlexander J Kallen
Aug 3, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anthony D SungMitchell E Horwitz
Nov 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara TomczykStephan Harbarth
Jan 14, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Katelyn A WhiteRonda L Cochran
Jul 14, 2020·Research Synthesis Methods·Simon L TurnerJoanne E McKenzie
Oct 3, 2020·Pharmaceutical Statistics·Val GebskiIan Marschner
Dec 24, 2018·Antimicrobial Resistance and Infection Control·Mark I GarveyElisabeth Holden
Jul 2, 2020·Clinical Epidemiology·Joycelyne E EwusieJemila S Hamid
May 28, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kyle R RizzoErin Epson
Mar 27, 2019·Antimicrobial Resistance and Infection Control·Mark I GarveyElisabeth Holden
Jun 5, 2020·Journal of Multidisciplinary Healthcare·Joycelyne E EwusieJemila S Hamid
Nov 26, 2020·Journal of General Internal Medicine·Dorothy Y HungSu-Ying Liang
Dec 12, 2020·Health Services Research·Dorothy Y HungSu-Ying Liang
Aug 30, 2020·The Science of the Total Environment·Jennifer D RunkleMargaret M Sugg
Nov 11, 2019·F1000Research·Anna Mae ScottPaul Glasziou
Aug 30, 2021·BMC Medical Research Methodology·Simon L TurnerJoanne E McKenzie

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Katherine EllingsonJohn A Jernigan
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Pei-Jean I FengJohn A Jernigan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Arno A MullerXavier Bertrand
© 2022 Meta ULC. All rights reserved